Jason Warren Lilly - 26 Oct 2023 Form 4 Insider Report for NEOGEN CORP (NEOG)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
31 Oct 2023, 12:11:19 UTC
Prior SEC filing
17 Oct 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Christopher Sefcheck (Attorney in Fact)

Key filing fact

Jason Warren Lilly filed Form 4 for NEOGEN CORP (NEOG) on 31 Oct 2023.

Key facts

  • This page summarizes Jason Warren Lilly's Form 4 filing for NEOGEN CORP (NEOG).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 31 Oct 2023, 12:11.

Change

  • Previous filing in this sequence was filed on 17 Oct 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NEOG transaction Derivative

Common Stock (Right to Buy)

Options Exercise

Transaction value
$0
Shares
+25,004
Change %
+12%
Price
$0.000000
Shares after
225,196
Date
26 Oct 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,004
Exercise price
$15.48
Footnotes
F1
NEOG transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
+14,574
Change %
+75%
Price
$0.000000
Shares after
34,038
Date
26 Oct 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
14,574
Exercise price
$15.48
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .